Show simple item record

dc.contributor.authorWorld Health Organizationen
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-16T15:00:17Z
dc.date.available2012-06-16T15:00:17Z
dc.date.created2011en
dc.date.issued2011en
dc.identifier.govdocWHO/HTM/TB/2011.4en
dc.identifier.isbn9789241501545
dc.identifier.urihttp://www.who.int/iris/handle/10665/44586
dc.descriptionWHO/HTM/TB/2011.4en
dc.description36 p.en
dc.language.isoenen
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subjectWHO guideline
dc.subject.meshTuberculosis, Multidrug-resistanten
dc.subject.meshTuberculosisen
dc.subject.meshRifampinen
dc.subject.meshMycobacterium tuberculosisen
dc.subject.meshHIV infectionsen
dc.subject.meshSensitivity and specificityen
dc.subject.meshGuidelineen
dc.subject.otherCommunicable Diseases and their Controlen
dc.titleAutomated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system: policy statementen
dc.subject.meshqualifierdiagnosisen
dc.subject.meshqualifierpharmacologyen
dc.subject.meshqualifierisolation and purificationen
who.relation.languageVersion10665/85528
who.relation.languageVersion10665/78139en


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record